1-42851017-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001242739.2(ZNF691):c.152G>A(p.Gly51Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000651 in 1,559,060 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001242739.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF691 | NM_001242739.2 | c.152G>A | p.Gly51Asp | missense_variant | 4/4 | ENST00000651192.1 | NP_001229668.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF691 | ENST00000651192.1 | c.152G>A | p.Gly51Asp | missense_variant | 4/4 | NM_001242739.2 | ENSP00000498913.1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000230 AC: 47AN: 204574Hom.: 0 AF XY: 0.000267 AC XY: 29AN XY: 108514
GnomAD4 exome AF: 0.000685 AC: 964AN: 1406854Hom.: 1 Cov.: 31 AF XY: 0.000697 AC XY: 484AN XY: 694688
GnomAD4 genome AF: 0.000335 AC: 51AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.152G>A (p.G51D) alteration is located in exon 4 (coding exon 2) of the ZNF691 gene. This alteration results from a G to A substitution at nucleotide position 152, causing the glycine (G) at amino acid position 51 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at